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The effect of multiple sclerosis (MS) on the ability to identify emotional expressions in faces was 
investigated, and possible associations with patients’ characteristics were explored. 56 non-demented MS 
patients and 56 healthy subjects (HS) with similar demographic characteristics performed an emotion 
recognition task (ERT), the Benton Facial Recognition Test (BFRT), and answered the Hospital Anxiety and 
Depression Scale (HADS). Additionally, MS patients underwent a neurological examination and a 
comprehensive neuropsychological evaluation. The ERT consisted of 42 pictures of faces (depicting anger, 
disgust, fear, happiness, sadness, surprise and neutral expressions) from the NimStim set. An iViewX high-
speed eye tracker was used to record eye movements during ERT. The fixation times were calculated for two 
regions of interest (i.e., eyes and rest of the face). No significant differences were found between MS and HC 
on ERT’s behavioral and oculomotor measures. Bivariate and multiple regression analyses revealed 
significant associations between ERT’s behavioral performance and demographic, clinical, 
psychopathological, and cognitive measures. 
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1.  INTRODUCTION 
Multiple sclerosis (MS) is a chronic, inflammatory and neurodegenerative disease of the central nervous 
system. It is characterized by destruction of myelin sheaths and axonal loss (Frischer et al, 2009). MS is the 
most common cause of neurologic disability in young adults, affecting ~1/1000 people in industrialized 
countries (Hogancamp et al, 1997). Cognitive impairments (Langdon, 2011) and mood disorders (Silva et al, 
2011), namely depression and anxiety, are relatively common in MS. 
Recent studies have reported impairments in MS patients’ ability to recognize emotions in facial 
expressions (Henry et al, 2009; Krause et al, 2009; Jehna et al, 2010; Phillips et al, 2011; Prochnow et al, 
2011). However, there are also studies that have not found significant differences between MS patients and 
healthy individuals in decoding emotions from facial stimuli (Di Bitonto et al, 2011; Jenha et al, 2011a,b). 
These apparent inconsistencies in the literature may reflect differences in MS samples (e.g., degree of 
neurologic disability, psychopathological symptoms, and cognitive functioning).  
This study aimed: 1) to explore the ability to recognize facial emotions in a cohort of MS patients without 
significant cognitive impairments, using a new set of stimuli, and 2) to explore possible associations with patients’ 
demographic, clinical, psychopathological, and cognitive characteristics. 
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2.  METHODS 
2.1  Participants 
The study included fifty-six patients diagnosed with MS (according to the McDonald Revised criteria; 
Polman et al, 2005) and recruited from the Neuroimmunology Outpatient Clinic from Hospital de Santo 
Antonio - Centro Hospitalar do Porto. The exclusion criteria were current or recent (i.e., within the previous 
30 days) MS exacerbation, other CNS disorder or serious medical illness that could interfere with mood, and 
Mini-Mental State Examination (MMSE) <=26. Patients’ mean time since clinical diagnosis was 9 years 
(SD=6.2); their mean age at onset was 29.93 years (SD=9.86); their mean Expanded Disability Status Scale 
(EDSS) score was 2.47 (SD=1.97); and their mean MMSE score was 29.29 (SD=0.90). The frequencies of 
MS clinical courses were: 48 (85.7%) relapsing-remitting, 3 (5.4%) secondary progressive, and 5 (8.9%) 
primary progressive. 
 The healthy control group (HC) included 56 individuals recruited in the community, without neurological 
or psychiatric disorders. All subjects provided informed written consent to participate in this study, as 
required by the Declaration of Helsinki.  
 
2.2  Procedures 
All participants performed the Emotion Recognition Test (ERT) and the Benton Facial Recognition Test, 
and completed the Hospital Anxiety and Depression Scale. The ERT consisted of labeling 42 pictures of 
faces depicting anger, disgust, fear, happiness, sadness, surprise and neutral expressions. For each emotion, 3 
pictures of women and 3 pictures of men were selected from the NimStim set (Tottenham et al, 2009). The 
NimStim set is a large, contemporary, multiracial database of color pictures of professional actors enacting a 
variety of expressions. The selected pictures of European-Americans (n=40) and African-Americans (n=2) 
were presented in pseudorandomized order; and had >70% of the normative sample agreed with the intended 
expression (Tottenham et al, 2009). The interval between trials was 1500 ms, with a fixation cross, to make 
sure that subjects were looking at the center of the screen at the beginning of each picture presentation. The 
pictures were aligned so that the tip of the nose of the faces corresponded to the center of the screen. After 3 
seconds of “free exploration” of the face, the response options (i.e., anger, disgust, fear, happiness, sadness, 
surprise and neutral) were added in a fixed order on the bottom of the screen and subjects were asked to 
choose among the 7 response options the one that better described the facial expression, by touching the 
desired response on the screen. There was no time limit for the response. The Presentation version 13.0 
software and a TFT Monitor 19’’ with touch screen (KTMT-1921-USB/B, Keytec) were used for stimuli 
presentation and behavioral response recording. The iView X™ Hi-Speed 1250 System, SensoMotoric 
Instruments, was used to record the eye movements during the first 3 seconds of each trial The behavioral 
responses were given by touch screen. The subject’s score corresponded to the number of correct responses 
(i.e., emotional labeling of the picture). The fixation times were calculated for two regions of interest (ROI): 
eyes and rest of the face. Due to technical problems, oculomotor data were not collected during ERT 
performance of 3 MS patients. 
Additionally, MS patients underwent a full neurological examination and a comprehensive 
neuropsychological evaluation (i.e., MMSE, Auditory Verbal Learning Test, Corsi-Block Test, Digit Span, 
Letter Word Fluency, Nine-Hole Peg Test, Sentence Repetition, and Wisconsin Card Sorting Test – Nelson’s 
version) (for tests descriptions read: Strauss et al, 2006). During the neurological examination, the following 
data were collected: age at onset, disease duration, disease course, and degree of disability defined by EDSS 
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3.1  MS vs. HC 
Table 1 shows that MS and HS were not significantly different on the demographic characteristics (i.e., 
gender, age, and education) and the visual perception abilities (i.e., BFRT). MS patients had higher 
depression scores on the HADS. However, the frequency of pathological anxiety (i.e., HADS – Anxiety 
=>11) and pathological depression (i.e., HADS – Depression =>11) were not statistically higher (p>0.05) for 
MS patients (respectively 21.4% and 8.9%) than HC subjects (respectively 8.9% and 5.4%). The groups’ 
ERT – behavioral and ERT – oculomotor results are presented in Table 2. No significant differences were 
found.  
Table 1. MS and HC characteristics and test results. 
  MS HC Chi-Square and 
Mann-Whitney  
Gender    
 Women 32 (57.1%) 31 (55.4%) 0.849 
 Men 24 (42.9%) 25 (43.6%)  
Age 38.95 (10.34) 37.39 (10.57) 0.433 
Education 13.21 (4.48) 13.77 (4.10) 0.497 
BFRT 23.42 (2.11) 23.55 (2.33) 0.749 
HADS     
 Anxiety 7.29 (4.31) 5.79 (3.35) 0.070 
 Depression 4.48 (3.98) 2.91 (3.05) 0.018 
 





% fixation time 
in ROI – eyes 
Mann-
Whitney  MS HC MS HC 
Anger 5.20 (1.15) 5.36 (0.94) 0.562 42.73 (22.13) 47.08  (20.54) 0.297 
Disgust 5.61 (0.78) 5.70 (0.63) 0.720 37.30 (20.52) 41.18 (20.43) 0.265 
Fear 4.21 (1.52) 4.45 (1.4) 0.458 42.72 (20) 44.52 (20.73) 0.658 
Happiness 5.66 (0.84) 5.66 (0.66) 0.556 42.42 (21.36) 46.06 (22.01) 0.300 
Neutral 4.84 (1.64) 5.02 (1.39) 0.585 45.19 (23.43) 49.09 (21.45) 0.347 
Surprise 5.41 (1.02) 5.55 (0.71) 0.883 39.49 (21.64) 44.76 (21.33) 0.238 
Sadness 4.66 (1.1) 4.93 (1.06) 0.182 46.35 (20.82) 46.44 (20.88) 0.686 
Total 35.59 (5.29) 36.66 (4.11) 0.400 42.35 (20.47) 45.63 (20.11) 0.347 
 
 
3.2  MS 
MS patients’ ERT – behavioral total score was significantly associated with age (r=-0.447), age at onset (r=-
0.276), EDSS (r=-0.423), HADS – anxiety (r=-0.366), and HADS – depression (r=-0.348) scores. More 
accurate responses on the ERT were also related with better performance on every neuropsychological 
measure (Table 3). No significant associations were found with disease duration or with any of the 
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oculomotor measures (i.e., fixation time on the ROI – eyes, fixation time on the ROI – rest of the face, and 
percentage of fixation time on the ROI – eyes). 
Multiple linear regression analyses were conducted with ERT – behavioral total score as the dependent 
variable. For the first analysis, the independent variables were: age, education, EDSS (<3 vs. =>3), MMSE, 
BFRT (<20 vs. =>20), HADS – anxiety (<11 vs. =>11), and HADS – depression (<11 vs. =>11). After 
applying the backward method and verifying the assumptions, the linear regression model was composed by 
the following variables: EDSS (β=-4.679; p<0.001), HADS – anxiety (β=-3.171; p=0.020), and HADS – 
depression (β=-4.226; p=0.033). These set of variables explained (R2) 65% of the ERT – behavioral variance.  
A series of multiple linear regression analyses were conducted using the following independent variables: 
age, education, EDSS (<3 vs. =>3), HADS – anxiety (<11 vs. =>11), HADS – depression (<11 vs. =>11), 
and one neuropsychological measure. No variable selection method was used. After verifying the 
assumptions, the following neuropsychological measures remained independently related to ERT – 
behavioral total score: Nine-Hole Peg Test– right hand (β=-0.121; p=0.048), Nine-Hole Peg Test – left hand 
(β=-0.114; p=0.042), and Wisconsin Card Sorting Test – categories (β=0.859; p=0.034), and Wisconsin Card 
Sorting Test – perseverative errors (β=-0.320; p=0.034). 
MS patients’ fixation time on the ROI – eyes (r=-0.337), fixation time on the ROI – rest of the face 
(r=0.348), and percentage of time in the ROI – eyes during the “free exploration” phase of ERT (r=-0.370) 
were only significantly (p<0.05) associated with EDSS. No significant associations were found between 
oculomotor measures and age, age at onset, HADS – anxiety, HADS – depression, or with any of the 
neuropsychological evaluation measures (Table 3).  
 
Table 3. Correlations between MS patients’ ERT and neuropsychological results 
  ERT 
 
Behavioral 
% fixation time 
in ROI – eyes 
Mini Mental State Examination 0.350 * 0.123 
Nine-Hole Peg Test   
 Right -0.389 * -0.020 
 Left -0.444 ** -0.022 
Digit Span 0.434** -0.160 
Corsi-Block Test 0.427** -0.178 
Benton Facial Recognition Test 0.342* 0.118 
Auditory Verbal Learning Test   
 Immediate Recall 0.421 ** 0.241 
 30’ Recall 0.431** 0.259 
Sentence Repetition 0.343 0.001 
Letter Word Fluency 0.381* 0.018 
Wisconsin Card Sorting Test   
 Categories 0.422** -0.160 
 Perseverative errors -0.406* 0.184 
 
* p<0.05    **p<0.01 
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MS patients without significant cognitive impairments showed a relatively preserved ability to label 
emotional expressions, as suggested by a lack of significant differences between MS patients and HC 
subjects on the number of correct responses. These negative results are consistent with previous reports 
(Jenha et al, 2011a; Di Bitonto et al, 2011). Nonetheless, recent fMRI studies have documented functional 
imaging differences in MS patients during emotion recognition, in the context of normal behavioral scores 
(Passamonti et al, 2009; Jenha et al, 2011b). These findings suggest that early stages of MS do not have a 
major effect on the ability to recognize emotions. However, subtle emotion processing differences are likely 
to occur.  
Similar to recent reports, MS patients’ recognition of emotions in facial expressions was negatively 
associated with higher disability index (Prochnow et al, 2011). The fixation time in the eye region of faces, 
essential for normal recognition of certain emotions (Adolphs et al., 2005), was also significantly associated 
with neurological disability. It is reasonable to speculate that patients in more advanced stages of MS, who 
have increasing lesion burden and atrophy, would have impaired emotion recognition of facial expressions 
(Benedict et al, 2004; Jehna et al, 2011a).  
Consistent with findings from other patient populations, negative mood was associated with poorer 
emotion recognition of facial expressions (Gur et al, 2011). Level of anxiety and depression, and degree of 
neurological disability explained approximately 65% of the total behavioral score on the ERT.  
Similar to previous reports (Henry et al, 2009; Jehna et al, 2010), accurate recognition of facial 
expressions was related to a series of neuropsychological tests, including measures of psychomotor speed and 
executive functions. These associations were not dependent of age, education, anxiety, depression, or degree 
of neurological disability. 
Disease severity, level of cognitive functioning, and mood states are important confounders in the study of 
emotional recognition of faces in MS. Future research studies ought to account for these dimensions. 
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